tiprankstipranks
Advertisement
Advertisement

PASG Stock Latest News

Passage Bio initiated with an Outperform at Oppenheimer
The FlyPassage Bio initiated with an Outperform at Oppenheimer
21d ago
PASG
QURE
Passage Bio Ends Hopewell Lab Lease, Extends Cash Runway
PremiumCompany Announcements
Passage Bio Ends Hopewell Lab Lease, Extends Cash Runway
1M ago
8K
PASG
Passage Bio price target lowered to $23 from $67 at Canaccord
PremiumThe Fly
Passage Bio price target lowered to $23 from $67 at Canaccord
2M ago
PASG
Passage Bio Reports 2025 Results, Advances FTD Program
PremiumCompany Announcements
Passage Bio Reports 2025 Results, Advances FTD Program
2M ago
8K
PASG
Passage Bio reports Q4 EPS ($4.09), consensus ($2.80)
PremiumThe Fly
Passage Bio reports Q4 EPS ($4.09), consensus ($2.80)
2M ago
PASG
Passage Bio sees cash runway through 1Q27
PremiumThe FlyPassage Bio sees cash runway through 1Q27
2M ago
PASG
Passage Bio: Market Overreaction to AAV Oncogenesis Risk Creates Compelling Buy Opportunity Ahead of 2026 PBFT02 Catalysts
Premium
Ratings
Passage Bio: Market Overreaction to AAV Oncogenesis Risk Creates Compelling Buy Opportunity Ahead of 2026 PBFT02 Catalysts
3M ago
PASG
Passage Bio Highlights PBFT02 Progress and Extended Cash Runway
Premium
Company Announcements
Passage Bio Highlights PBFT02 Progress and Extended Cash Runway
3M ago
8K
PASG
Two new option listings and eighteen option delistings on December 22nd
PremiumThe Fly
Two new option listings and eighteen option delistings on December 22nd
4M ago
QD
EPS
Passage Bio initiated with a Buy at Lucid Capital
PremiumThe Fly
Passage Bio initiated with a Buy at Lucid Capital
5M ago
PASG
PASG Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PASG Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
PASG
3 Best Biotech Stocks to Buy Now, 11/12/2025, According to Top Analysts
PremiumMarket News
3 Best Biotech Stocks to Buy Now, 11/12/2025, According to Top Analysts
5M ago
UPB
BNTX
Passage Bio’s Growth Potential Highlighted by Clinical Progress and Regulatory Alignment
PremiumRatingsPassage Bio’s Growth Potential Highlighted by Clinical Progress and Regulatory Alignment
5M ago
PASG
Passage Bio Reports Q3 Financial Results and Updates
Premium
Company Announcements
Passage Bio Reports Q3 Financial Results and Updates
5M ago
8K
PASG
Passage Bio reports Q3 EPS ($2.44), consensus ($2.97)
Premium
The Fly
Passage Bio reports Q3 EPS ($2.44), consensus ($2.97)
5M ago
PASG
Passage Bio’s PBFT02 Study: A Promising Step in Gene Therapy for Dementia
PremiumCompany Announcements
Passage Bio’s PBFT02 Study: A Promising Step in Gene Therapy for Dementia
6M ago
PASG
Optimistic Outlook for Passage Bio’s PBFT02: Promising Data and Potential FDA Support
PremiumRatings
Optimistic Outlook for Passage Bio’s PBFT02: Promising Data and Potential FDA Support
6M ago
PASG
Promising Developments and Strong Financial Outlook Reinforce Buy Rating for Passage Bio
PremiumRatings
Promising Developments and Strong Financial Outlook Reinforce Buy Rating for Passage Bio
8M ago
PASG
Passage Bio price target lowered to $67 from $260 at Canaccord
PremiumThe Fly
Passage Bio price target lowered to $67 from $260 at Canaccord
8M ago
PASG
Passage Bio Reports Q2 2025 Progress and Financials
PremiumCompany AnnouncementsPassage Bio Reports Q2 2025 Progress and Financials
8M ago
PASG
Passage Bio Reports Promising Q2 2025 Financial Results
Premium
Company Announcements
Passage Bio Reports Promising Q2 2025 Financial Results
8M ago
8K
PASG
Passage Bio reports Q2 EPS ($2.96) vs ($5.09) last year
Premium
The Fly
Passage Bio reports Q2 EPS ($2.96) vs ($5.09) last year
8M ago
PASG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >